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Cardiac energy metabolism is complex and has three main
components: 1. Substrate utilisation, 2 Oxydative phosphorilation
and 3. Transfer of high energy phosphates. Substrate utilization
involves the cellular uptake of free fatty acids, glucose and amino
acids, their breakdown by beta-oxidation and glycolysis, and the
entry of Acetyl Coenzyme A into the Krebs cycle. Oxidative
phosphorylation involves the production of energy by the mito-
chondrial respiratory chain and the production of high-energy
phosphates.
Until recent it was not known that it was possible to delimitate
the infarct size through therapeutic interventions. Likely, the
improvement to understand the mechanisms of cellular survivor
occurs in that year, when Murry et al. discovered an intrinsic
mechanism of myocardial protection, which they denominated as
ischemic preconditioning. In that experiment, it was observed that
four cycles of ﬁve minutes of ischemia, with intermittent reperfusion,
before 40 min of ischemia period, resulted in reduction of 75% of the
infarct size. Also, it was demonstrated by these researches that this
protection it was not resulted by collateral overture and that
protective effect of the ischemic preconditioning was abolished in
the presence of prolonged ischemia, with duration of 3 h.
Two phenomenons, the walk-through angina and the warm up
phenomenon could represent a clinical manifestation of precondi-
tioning. The phenomenon of walk-through angina was ﬁrst related in
the end of century XVIII in a patient that developed angina during
the effort, but experimented the paradox disappearing of the pain
with the exercise continuation. The exact molecular mechanisms
involved in ischemic preconditioning are not fully elucidated.
Therefore, due to the high prevalence of risk factors to cardio-
vascular diseases and the high morbidity and mortality associated
with coronary artery disease, there is a needed to understand even
better the cardiac metabolism during ischemia and the strategies to
reduce the consequences of the ischemia, to preserve the viability of
the ischemic myocardium.
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The diffuse distribution of atherosclerosis in patients with type 2
diabetes mellitus is related in part to the metabolic derangements of
diabetes and in part to the clustering of different risk factors such as
elevated blood pressure, central obesity and altered lipid proﬁle.
In patients with diabetes mellitus and coronary artery disease the
metabolic changes occurring as a consequence of the mismatch
between blood supply and cardiac metabolic requirements are
heightened by the diabetic metabolic changes. The presence of
myocardial insulin resistance has been demonstrated in diabetic
patients with and without coronary artery disease suggesting that
even early stages of altered glycaemic control may affect myocardial
metabolism and predispose to the diabetic cardiomyopathy. Several
metabolic alterations occur in the pre-diabetic and in the diabetic
state that may heighten the effect of myocardial ischemia and
contribute to the development of diabetic cardiomyopathy.
In diabetics and in subjects with insulin resistance the abnormal-
ities in glucose uptake and utilization are coupled with an increase in
free fatty acid oxidation not only in the skeletal myocytes but also in
the cardiomyocytes. These metabolic changes of the diabetic heart
and skeletal myocytes lead to a diminished production of high
energy phosphate since the beta-oxidation of free fatty acid is less
efﬁcient than the glycolysis in generating energy.
In diabetic and pre-diabetic states a reduced glucose uptake and
utilization coupled with a preferential FFA oxidation occur as
consequence of inadequate insulin receptor signalling or decreased
insulin levels. An important metabolic alteration of diabetes is the
increase free fatty acid concentrations and increased muscular and
myocardial free fatty acid uptake and oxidation. The increased
uptake and utilization of free fatty acid during increased metabolic
demands or during ischemia is responsible for greater decrease of
myocardial performance for given amount of ischemia compared to
non diabetic hearts and for the increased susceptibility of diabetic
heart to myocardial ischemia.
Therefore, the abnormal increase in free fatty acid uptake and
utilization contributes to both the development of contractile
dysfunction and to increased sensitivity of the heart to injury during
ischemia. Furthermore, the decreased energy production of the
diabetic heart related to the decreased glucose utilization and
preferential free fatty acid oxidation leads to important alterations
in calcium homeostasis that are responsible for the impaired systolic
and diastolic function of the diabetic heart.
In diabetic patients with coronary artery disease a therapeutic
approach aimed at an improvement of cardiac metabolism through
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